115 related articles for article (PubMed ID: 3495005)
21. Synergism in the activation of human CD8 T cells by cross-linking the T-cell receptor complex with the CD8 differentiation antigen.
Emmrich F; Strittmatter U; Eichmann K
Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8298-302. PubMed ID: 3095833
[TBL] [Abstract][Full Text] [Related]
22. Clinical and immunological studies in advanced cancer patients sequentially treated with anti CD3 monoclonal antibody (OKT3) and interleukin-2.
Borrione P; Montacchini L; Beggiato E; Pileri A; Bianchi A; Massaia M
Leuk Lymphoma; 1996 Apr; 21(3-4):325-30. PubMed ID: 8726415
[TBL] [Abstract][Full Text] [Related]
23. Induction of monocyte procoagulant activity with OKT3 antibody.
Iitaka M; Iwatani Y; Row VV; Volpé R
J Immunol; 1987 Sep; 139(5):1617-23. PubMed ID: 3114371
[TBL] [Abstract][Full Text] [Related]
24. Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
Schwab R; Crow MK; Russo C; Weksler ME
J Immunol; 1985 Sep; 135(3):1714-8. PubMed ID: 3926880
[TBL] [Abstract][Full Text] [Related]
25. Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen.
Phillips JH; Lanier LL
J Immunol; 1986 Mar; 136(5):1579-85. PubMed ID: 2419407
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
Damle NK; Doyle LV; Bradley EC
J Immunol; 1986 Nov; 137(9):2814-22. PubMed ID: 2944965
[TBL] [Abstract][Full Text] [Related]
27. Human T cell antigens involved in cytotoxicity against allogeneic or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with effector-target cell binding and of the T3/Leu 4 antigen with triggering.
Platsoucas CD
Eur J Immunol; 1984 Jun; 14(6):566-77. PubMed ID: 6610558
[TBL] [Abstract][Full Text] [Related]
28. Activation of human peripheral blood mononuclear cells by anti-T3: killing of tumor target cells coated with anti-target-anti-T3 conjugates.
Jung G; Honsik CJ; Reisfeld RA; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4479-83. PubMed ID: 3086885
[TBL] [Abstract][Full Text] [Related]
29. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
Smyth MJ; Norihisa Y; Ortaldo JR
J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
[TBL] [Abstract][Full Text] [Related]
30. Human T lymphocyte activation by monoclonal antibodies; OKT3, but not UCHT1, triggers mitogenesis via an interleukin 2-dependent mechanism.
Van Wauwe JP; Goossens JG; Beverley PC
J Immunol; 1984 Jul; 133(1):129-32. PubMed ID: 6327822
[TBL] [Abstract][Full Text] [Related]
31. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide.
Munakata T; Semba U; Shibuya Y; Kuwano K; Akagi M; Arai S
J Immunol; 1985 Apr; 134(4):2449-55. PubMed ID: 3919096
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.
Wong JT; Pinto CE; Gifford JD; Kurnick JT; Kradin RL
J Immunol; 1989 Nov; 143(10):3404-11. PubMed ID: 2509557
[TBL] [Abstract][Full Text] [Related]
33. T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex.
Ceuppens JL; Bloemmen FJ; Van Wauwe JP
J Immunol; 1985 Dec; 135(6):3882-6. PubMed ID: 2933454
[TBL] [Abstract][Full Text] [Related]
34. Activation through CD3 molecule leads to clonal expansion of all human peripheral blood T lymphocytes: functional analysis of clonally expanded cells.
Weber WE; Buurman WA; Vandermeeren MM; Raus JC
J Immunol; 1985 Oct; 135(4):2337-42. PubMed ID: 3875651
[TBL] [Abstract][Full Text] [Related]
35. Accessory cell independent proliferation of human T4 cells stimulated by immobilized monoclonal antibodies to CD3.
Geppert TD; Lipsky PE
J Immunol; 1987 Mar; 138(6):1660-6. PubMed ID: 3102594
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
[TBL] [Abstract][Full Text] [Related]
37. Lymphokine-activated-killer-mediated lysis of cells infected with typhus group rickettsiae can be inhibited by OKT3 monoclonal antibody.
Carl M; Dasch GA
Infect Immun; 1986 Jul; 53(1):226-8. PubMed ID: 3087881
[TBL] [Abstract][Full Text] [Related]
38. Induction of interleukin 2 receptiveness and proliferation in resting peripheral T cells by monoclonal anti-CD3 (T3) antibodies does not require the presence of macrophages.
Stingl LA; Sinska A; Landesmann U; Smolen JS
Clin Exp Immunol; 1987 Apr; 68(1):146-55. PubMed ID: 3115639
[TBL] [Abstract][Full Text] [Related]
39. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8.
Kansas GS; Wood GS; Fishwild DM; Engleman EG
J Immunol; 1985 May; 134(5):2995-3002. PubMed ID: 3156924
[TBL] [Abstract][Full Text] [Related]
40. Activation of T cells by cross-linking an anti-CD3 antibody with a second anti-T cell antibody: mechanism and subset-specific activation.
Walker C; Bettens F; Pichler WJ
Eur J Immunol; 1987 Jun; 17(6):873-80. PubMed ID: 2439351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
